Fatal Strongyloides hyper-infection in a patient with myasthenia gravis
Purpose We report a fatal case of Strongyloides hyper-infection as the result of corticosteroid therapy of a patient with myasthenia gravis. Case presentation Our patient was a farmer with a past history of living in an endemic area for Strongyloides stercoralis in Iran. Hyper-infection was diagnose...
Gespeichert in:
| Veröffentlicht in: | Infection 2014-12, Vol.42 (6), p.1039-1042 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1042 |
|---|---|
| container_issue | 6 |
| container_start_page | 1039 |
| container_title | Infection |
| container_volume | 42 |
| creator | Saraei, M. Hosseinbigi, B. Shahnazi, M. Bijani, B. |
| description | Purpose
We report a fatal case of
Strongyloides
hyper-infection as the result of corticosteroid therapy of a patient with myasthenia gravis.
Case presentation
Our patient was a farmer with a past history of living in an endemic area for
Strongyloides stercoralis
in Iran. Hyper-infection was diagnosed during the advanced-stage disease by demonstration of enormous number of larvae in the direct smears prepared from both the stool and tracheal secretions. Unfortunately, despite appropriate anti-parasite therapy, the patient died due to respiratory failure.
Conclusion
We recommend the provision of more awareness in high-risk people prior to immunosuppressive therapy, through screening for
S. stercoralis
, even in non-endemic regions. |
| doi_str_mv | 10.1007/s15010-014-0637-x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1622210648</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3490773531</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-d078c36362c5aafe629d5a13921efc4189a8703c8c32450acd840fca91120b053</originalsourceid><addsrcrecordid>eNp1kD1PwzAQhi0EoqXwA1hQJGbD-SNOMqKKFqRKDMBsuY7TumqdYrvQ_HtcpSAWphvued_TPQhdE7gjAMV9IDkQwEA4BsEKvD9BQ8JZhaEq2CkaAgPAJaFigC5CWAFAXvHiHA0oLwsiqBii6URFtc5eo2_dolu3tjYhW3Zb47F1jdHRti6zLlPZVkVrXMy-bFxmm06FuDTOqmzh1acNl-isUetgro5zhN4nj2_jJzx7mT6PH2ZYc8gjrqEoNRNMUJ0r1RhBqzpXhFWUmEZzUlaqLIDpBFGeg9J1yaHRqiKEwhxyNkK3fe_Wtx87E6JctTvv0kmZHqKUgOBlokhPad-G4E0jt95ulO8kAXlQJ3t1MqmTB3VynzI3x-bdfGPq38SPqwTQHghp5RbG_zn9b-s3Xx15Fg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1622210648</pqid></control><display><type>article</type><title>Fatal Strongyloides hyper-infection in a patient with myasthenia gravis</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Saraei, M. ; Hosseinbigi, B. ; Shahnazi, M. ; Bijani, B.</creator><creatorcontrib>Saraei, M. ; Hosseinbigi, B. ; Shahnazi, M. ; Bijani, B.</creatorcontrib><description>Purpose
We report a fatal case of
Strongyloides
hyper-infection as the result of corticosteroid therapy of a patient with myasthenia gravis.
Case presentation
Our patient was a farmer with a past history of living in an endemic area for
Strongyloides stercoralis
in Iran. Hyper-infection was diagnosed during the advanced-stage disease by demonstration of enormous number of larvae in the direct smears prepared from both the stool and tracheal secretions. Unfortunately, despite appropriate anti-parasite therapy, the patient died due to respiratory failure.
Conclusion
We recommend the provision of more awareness in high-risk people prior to immunosuppressive therapy, through screening for
S. stercoralis
, even in non-endemic regions.</description><identifier>ISSN: 0300-8126</identifier><identifier>EISSN: 1439-0973</identifier><identifier>DOI: 10.1007/s15010-014-0637-x</identifier><identifier>PMID: 24871626</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject><![CDATA[Albendazole - administration & dosage ; Antinematodal Agents - administration & dosage ; Case Report ; Endemic Diseases ; Family Medicine ; Fatal Outcome ; General Practice ; Humans ; Immunocompromised Host ; Immunosuppressive Agents - administration & dosage ; Immunosuppressive Agents - adverse effects ; Infectious Diseases ; Internal Medicine ; Iran - epidemiology ; Ivermectin - administration & dosage ; Larvae ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Myasthenia Gravis - drug therapy ; Myasthenia Gravis - immunology ; Myasthenia Gravis - parasitology ; Parasites ; Prednisolone - administration & dosage ; Prednisolone - adverse effects ; Strongyloidiasis - diagnosis ; Strongyloidiasis - drug therapy ; Strongyloidiasis - epidemiology ; Strongyloidiasis - immunology]]></subject><ispartof>Infection, 2014-12, Vol.42 (6), p.1039-1042</ispartof><rights>Springer-Verlag Berlin Heidelberg 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-d078c36362c5aafe629d5a13921efc4189a8703c8c32450acd840fca91120b053</citedby><cites>FETCH-LOGICAL-c405t-d078c36362c5aafe629d5a13921efc4189a8703c8c32450acd840fca91120b053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s15010-014-0637-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s15010-014-0637-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24871626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saraei, M.</creatorcontrib><creatorcontrib>Hosseinbigi, B.</creatorcontrib><creatorcontrib>Shahnazi, M.</creatorcontrib><creatorcontrib>Bijani, B.</creatorcontrib><title>Fatal Strongyloides hyper-infection in a patient with myasthenia gravis</title><title>Infection</title><addtitle>Infection</addtitle><addtitle>Infection</addtitle><description>Purpose
We report a fatal case of
Strongyloides
hyper-infection as the result of corticosteroid therapy of a patient with myasthenia gravis.
Case presentation
Our patient was a farmer with a past history of living in an endemic area for
Strongyloides stercoralis
in Iran. Hyper-infection was diagnosed during the advanced-stage disease by demonstration of enormous number of larvae in the direct smears prepared from both the stool and tracheal secretions. Unfortunately, despite appropriate anti-parasite therapy, the patient died due to respiratory failure.
Conclusion
We recommend the provision of more awareness in high-risk people prior to immunosuppressive therapy, through screening for
S. stercoralis
, even in non-endemic regions.</description><subject>Albendazole - administration & dosage</subject><subject>Antinematodal Agents - administration & dosage</subject><subject>Case Report</subject><subject>Endemic Diseases</subject><subject>Family Medicine</subject><subject>Fatal Outcome</subject><subject>General Practice</subject><subject>Humans</subject><subject>Immunocompromised Host</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Infectious Diseases</subject><subject>Internal Medicine</subject><subject>Iran - epidemiology</subject><subject>Ivermectin - administration & dosage</subject><subject>Larvae</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Myasthenia Gravis - drug therapy</subject><subject>Myasthenia Gravis - immunology</subject><subject>Myasthenia Gravis - parasitology</subject><subject>Parasites</subject><subject>Prednisolone - administration & dosage</subject><subject>Prednisolone - adverse effects</subject><subject>Strongyloidiasis - diagnosis</subject><subject>Strongyloidiasis - drug therapy</subject><subject>Strongyloidiasis - epidemiology</subject><subject>Strongyloidiasis - immunology</subject><issn>0300-8126</issn><issn>1439-0973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kD1PwzAQhi0EoqXwA1hQJGbD-SNOMqKKFqRKDMBsuY7TumqdYrvQ_HtcpSAWphvued_TPQhdE7gjAMV9IDkQwEA4BsEKvD9BQ8JZhaEq2CkaAgPAJaFigC5CWAFAXvHiHA0oLwsiqBii6URFtc5eo2_dolu3tjYhW3Zb47F1jdHRti6zLlPZVkVrXMy-bFxmm06FuDTOqmzh1acNl-isUetgro5zhN4nj2_jJzx7mT6PH2ZYc8gjrqEoNRNMUJ0r1RhBqzpXhFWUmEZzUlaqLIDpBFGeg9J1yaHRqiKEwhxyNkK3fe_Wtx87E6JctTvv0kmZHqKUgOBlokhPad-G4E0jt95ulO8kAXlQJ3t1MqmTB3VynzI3x-bdfGPq38SPqwTQHghp5RbG_zn9b-s3Xx15Fg</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Saraei, M.</creator><creator>Hosseinbigi, B.</creator><creator>Shahnazi, M.</creator><creator>Bijani, B.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope></search><sort><creationdate>20141201</creationdate><title>Fatal Strongyloides hyper-infection in a patient with myasthenia gravis</title><author>Saraei, M. ; Hosseinbigi, B. ; Shahnazi, M. ; Bijani, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-d078c36362c5aafe629d5a13921efc4189a8703c8c32450acd840fca91120b053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Albendazole - administration & dosage</topic><topic>Antinematodal Agents - administration & dosage</topic><topic>Case Report</topic><topic>Endemic Diseases</topic><topic>Family Medicine</topic><topic>Fatal Outcome</topic><topic>General Practice</topic><topic>Humans</topic><topic>Immunocompromised Host</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Infectious Diseases</topic><topic>Internal Medicine</topic><topic>Iran - epidemiology</topic><topic>Ivermectin - administration & dosage</topic><topic>Larvae</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Myasthenia Gravis - drug therapy</topic><topic>Myasthenia Gravis - immunology</topic><topic>Myasthenia Gravis - parasitology</topic><topic>Parasites</topic><topic>Prednisolone - administration & dosage</topic><topic>Prednisolone - adverse effects</topic><topic>Strongyloidiasis - diagnosis</topic><topic>Strongyloidiasis - drug therapy</topic><topic>Strongyloidiasis - epidemiology</topic><topic>Strongyloidiasis - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saraei, M.</creatorcontrib><creatorcontrib>Hosseinbigi, B.</creatorcontrib><creatorcontrib>Shahnazi, M.</creatorcontrib><creatorcontrib>Bijani, B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><jtitle>Infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saraei, M.</au><au>Hosseinbigi, B.</au><au>Shahnazi, M.</au><au>Bijani, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fatal Strongyloides hyper-infection in a patient with myasthenia gravis</atitle><jtitle>Infection</jtitle><stitle>Infection</stitle><addtitle>Infection</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>42</volume><issue>6</issue><spage>1039</spage><epage>1042</epage><pages>1039-1042</pages><issn>0300-8126</issn><eissn>1439-0973</eissn><abstract>Purpose
We report a fatal case of
Strongyloides
hyper-infection as the result of corticosteroid therapy of a patient with myasthenia gravis.
Case presentation
Our patient was a farmer with a past history of living in an endemic area for
Strongyloides stercoralis
in Iran. Hyper-infection was diagnosed during the advanced-stage disease by demonstration of enormous number of larvae in the direct smears prepared from both the stool and tracheal secretions. Unfortunately, despite appropriate anti-parasite therapy, the patient died due to respiratory failure.
Conclusion
We recommend the provision of more awareness in high-risk people prior to immunosuppressive therapy, through screening for
S. stercoralis
, even in non-endemic regions.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>24871626</pmid><doi>10.1007/s15010-014-0637-x</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0300-8126 |
| ispartof | Infection, 2014-12, Vol.42 (6), p.1039-1042 |
| issn | 0300-8126 1439-0973 |
| language | eng |
| recordid | cdi_proquest_journals_1622210648 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Albendazole - administration & dosage Antinematodal Agents - administration & dosage Case Report Endemic Diseases Family Medicine Fatal Outcome General Practice Humans Immunocompromised Host Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - adverse effects Infectious Diseases Internal Medicine Iran - epidemiology Ivermectin - administration & dosage Larvae Male Medicine Medicine & Public Health Middle Aged Myasthenia Gravis - drug therapy Myasthenia Gravis - immunology Myasthenia Gravis - parasitology Parasites Prednisolone - administration & dosage Prednisolone - adverse effects Strongyloidiasis - diagnosis Strongyloidiasis - drug therapy Strongyloidiasis - epidemiology Strongyloidiasis - immunology |
| title | Fatal Strongyloides hyper-infection in a patient with myasthenia gravis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T05%3A41%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fatal%20Strongyloides%20hyper-infection%20in%20a%20patient%20with%20myasthenia%20gravis&rft.jtitle=Infection&rft.au=Saraei,%20M.&rft.date=2014-12-01&rft.volume=42&rft.issue=6&rft.spage=1039&rft.epage=1042&rft.pages=1039-1042&rft.issn=0300-8126&rft.eissn=1439-0973&rft_id=info:doi/10.1007/s15010-014-0637-x&rft_dat=%3Cproquest_cross%3E3490773531%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1622210648&rft_id=info:pmid/24871626&rfr_iscdi=true |